Activin and Inhibin

Dazcapistat is a potent calpain inhibitor, with IC 50 s of &lt:3 μM for calpain 1, calpain 2 and calpain 9, respectively (patent WO2018064119A1, compound 405).Form:Solid.

Dazcapistat is a potent calpain inhibitor, with IC 50 s of &lt:3 μM for calpain 1, calpain 2 and calpain 9, respectively (patent WO2018064119A1, compound 405).Form:Solid.

Dazcapistat is a potent calpain inhibitor, with IC 50 s of &lt:3 μM for calpain 1, calpain 2 and calpain 9, respectively (patent WO2018064119A1, compound 405).Form:Solid.

Dazcapistat is a potent calpain inhibitor, with IC 50 s of &lt:3 μM for calpain 1, calpain 2 and calpain 9, respectively (patent WO2018064119A1, compound 405).

DB008 is potent and selective PARP16 inhibitor with an IC 50 value of 0.27 μM, containing an acrylamide electrophilic reagent. DB008 is membrane-permeable and marks PARP16 selectively.Appearance:SolidIC50&amp: Target:PARP16 0.27 μM (IC 50 )In

DB008 is potent and selective PARP16 inhibitor with an IC 50 value of 0.27 μM, containing an acrylamide electrophilic reagent. DB008 is membrane-permeable and marks PARP16 selectively.Appearance:SolidIC50&amp: Target:PARP16 0.27 μM (IC 50 )In

DB008 is potent and selective PARP16 inhibitor with an IC 50 value of 0.27 μM, containing an acrylamide electrophilic reagent. DB008 is membrane-permeable and marks PARP16 selectively.Appearance:SolidIC50&amp: Target:PARP16 0.27 μM (IC 50 )In

DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM: no inhibition on DDP8 and DPP9.IC50 value: 15 nM Target: DPP4 inhibitorDBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than

DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM: no inhibition on DDP8 and DPP9.IC50 value: 15 nM Target: DPP4 inhibitorDBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than

DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM: no inhibition on DDP8 and DPP9.IC50 value: 15 nM Target: DPP4 inhibitorDBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than

DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM: no inhibition on DDP8 and DPP9.IC50 value: 15 nM Target: DPP4 inhibitorDBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than

DC-BPi-11 hydrochloride is an inhibitor of bromodomain PHD finger transcription factor (BPTF), with an IC 50 value of 698 nM. DC-BPi-11 hydrochloride shows remarkable inhibition against leukemia cell proliferation.Appearance:SolidIC50&amp: